1. HBW Insight
  2. >>Geography
  3. >>International

EWG Sunscreen Assessment Finds Oxybenzone Use Slowing, But Shows Most Still Are ‘Inadequate’

 
• By Eileen Francis

Environmental Working Group’s annual “‘Guide to Sunscreens” finds 30% of non-mineral sunscreen products contain controversial ingredient oxybenzone, down from 40% last year and 60% three years ago.

• Source: Alamy

The Environmental Working Group’s annual “Guide to Sunscreens” finds the industry is moving away from using active ingredient oxybenzone, with 261 of 842 non-mineral sunscreens, around 30%, containing the substance.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

More from Geography

EU Parliament Agrees To Postpone Due Diligence And Sustainability Reporting Rules

 
• By David Ridley

Speaking at a recent AESGP webinar, sustainability expert Onur Durmus called the the European Commission’s “Omnibus” proposals - designed to simplify ESG reporting rules and recently supported by EU Parliament - a “positive development” for the European consumer health industry.

‘The Only Certainty Is Uncertainty’ In The UK’s Consumer Health Market

 
• By David Ridley

While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.

Over The Counter: Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls

 
• By David Ridley

HBW Insight catches up with PAGB CEO Michelle Riddalls to chat about the association's new five year plan. Riddalls also reflects on the successes of the last five years, including relaunching the UK Reclassification Alliance, which has published a list of Rx-to-OTC switches the government would like to see applications for. Part one of two.